66220-017 : Ethyol 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution

Labeler: Cumberland Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Ethyol
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: NDA020221
Rev. Date: 

NDC Package Codes:

  • 66220-017-03: 3 VIAL, SINGLE‑USE IN 1 CARTON (66220‑017‑03) > 10 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Amifostine

Dosage Strength:

  • 500 mg/10mL

Pharmaceutical Classes:

  • Cytoprotective Agent [EPC]
  • Free Radical Scavenging Activity [MoA]

Related Products:

Based on records with the same trade name.
  • 76310-017 Ethyol 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Clinigen Group Plc


Scan the QR code below to easily reference this data in the future:

NDC 66220-017 QR Code

< Prev: 66215-628Next: 66220-110 >

Related Discussions:

Amifostine suppository
radiaation therapy ## Manufacturing formula of Amifostine suppository & one of the article of this topic. ## Amifost... 2 replies
Subcutaneous Amifostine
The article on amifostine says it can ONLY be administered intravenously but this is NOT TRUE. Subcutaneous injection of...
Manufacturing formula of Amifostine Suppository
Amifostine 500 mg Suppository...

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 2 September 2016.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA